A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
Rivera N, Everett-Grueter CA, Edgerton DS, Rodewald T, Neal DW, Nishimura E, Larsen MO, Jacobsen LO, Kristensen K, Brand CL, Cherrington AD.
Rivera N, et al. Among authors: edgerton ds.
J Pharmacol Exp Ther. 2007 May;321(2):743-52. doi: 10.1124/jpet.106.115717. Epub 2007 Feb 16.
J Pharmacol Exp Ther. 2007.
PMID: 17308040